Prophylactic antibiotherapy with macrolides is commonly used to prevent bronchiectasis exacerbations. Indeed, there is evidence that macrolides possess immunomodulatory and anti-inflammatory properties, which explains their possible efficacy in this condition despite the presence of resistant germs. This treatment seems to improve the clinical evolution of bronchectasis and to reduce the frequency and intensity of the exacerbations.
View Article and Find Full Text PDFWe describe two patients who had skin infection due to identical strains of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) after returning from the Philippines. Both patients did not share risk factors for CA-MRSA acquisition besides scuba diving. Scuba diving equipment may represent a possible new mode of acquisition of CA-MRSA.
View Article and Find Full Text PDF